Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

BACKGROUND: Checkpoint inhibitors (CPIs) are thought to be effective against cutaneous melanoma in part because of the large burden of somatic mutations (neoantigens) generated from exposure to ultraviolet radiation. However, rare melanoma subtypes arising from acral skin, mucosal surfaces, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Klemen, Nicholas D., Wang, Melinda, Rubinstein, Jill C., Olino, Kelly, Clune, James, Ariyan, Stephan, Cha, Charles, Weiss, Sarah A., Kluger, Harriet M., Sznol, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103823/
https://www.ncbi.nlm.nih.gov/pubmed/32209601
http://dx.doi.org/10.1136/jitc-2019-000341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103823/
https://www.ncbi.nlm.nih.gov/pubmed/32209601
http://dx.doi.org/10.1136/jitc-2019-000341

Ejemplares similares